Activation of leukocyte rolling by the cysteine-rich domain and the hyper-variable region of HF3, a snake venom hemorrhagic metalloproteinase  by Menezes, Milene C. et al.
FEBS Letters 582 (2008) 3915–3921Activation of leukocyte rolling by the cysteine-rich domain
and the hyper-variable region of HF3, a snake venom
hemorrhagic metalloproteinase
Milene C. Menezesa, Adriana F. Paes Lemea, Robson L. Meloa, Carlos A. Silvaa,
Maisa Della Casab, Fernanda M. Brunia, Carla Limaa, Moˆnica Lopes-Ferreiraa,
Antonio C.M. Camargoa, Jay W. Foxc, Solange M.T. Serranoa,*
a Laborato´rio Especial de Toxinologia Aplicada-CAT/CEPID, Instituto Butantan, Av. Vital Brasil 1500, 05503-900 Sa˜o Paulo, Brazil
b Laborato´rio de Imunopatologia, Instituto Butantan, Av. Vital Brasil 1500, 05503-900 Sa˜o Paulo, Brazil
c Department of Microbiology, University of Virginia, Charlottesville, VA 22908, USA
Received 14 August 2008; revised 8 October 2008; accepted 22 October 2008
Available online 31 October 2008
Edited by Masayuki MiyasakaAbstract The functionality of the disintegrin-like/cysteine-rich
domains of snake venom metalloproteinases (SVMPs) has been
shown to reside in the cysteine-rich region, which can interact
with VWA-containing proteins. Recently, the hyper-variable re-
gion (HVR) of the cysteine-rich domain was suggested to consti-
tute a potential protein–protein adhesive interface. Here we show
that recombinant proteins of HF3, a hemorrhagic P-III SVMP,
containing the cysteine-rich domain (disintegrin-like/cysteine-
rich and cysteine-rich proteins) but not the disintegrin-like pro-
tein were able to signiﬁcantly increase leukocyte rolling in the
microcirculation. Peptides from the HVR also promoted leuko-
cyte rolling and this activity was inhibited by anti-alphaM/beta2
antibodies. These results show, for the ﬁrst time, that the cys-
teine-rich domain and its HVR play a role in triggering pro-
inﬂammatory eﬀects mediated by integrins.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Snake venom metalloproteinase1. Introduction
Local tissue destruction due to snake envenomation involves
activation of the immune response in which the cascade of
events is usually initiated by tissue macrophages and blood
monocytes [1,2]. SVMPs are found mainly in viper venoms,
and are primarily responsible for the observed hemorrhage
due to the disruption of blood vessels as well as for inhibition
of platelet-aggregation [3]. These enzymes have also been impli-
cated in the local pro-inﬂammatory pathogenesis [2,4]. They are
members of the Reprolysin subfamily of metalloproteinases,
which also includes two groups ofmammalian homologous pro-
teins, A Disintegrin And Metalloproteinase (ADAM) and A
Disintegrin AndMetalloproteinase with ThrombospondinMo-
tifs (ADAMTS) [4]. SVMPs are divided into three main classes
depending on their domain organization [5]. The P-III class of
SVMPs and the ADAMs and ADAMTSs share homologous*Corresponding author. Fax: +55 11 3726 1024.
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[5]. The disintegrin-like/cysteine-rich domains of SVMPs have
been shown to play a role in the inhibition of collagen-stimu-
lated platelet-aggregation promoted by these enzymes [6,7].
Members of theADAMs group have been implicated in the con-
trol of membrane fusion, cytokine and growth factor shedding,
and cell migration [8]. Accumulated evidence in the literature
suggests that the disintegrin-like/cysteine-rich domains of the
SVMPs as well as those of the ADAMs and ADAMTSs are in-
volved in their interactions with speciﬁc ligands [5,9,10]. Vari-
ous studies have shown that the functionality attributed to the
disintegrin-like/cysteine-rich domains of SVMPs resides in the
cysteine-rich domain region [11–13]. The biological activities
attributed to this domain result from its ability to interact with
other proteins, such as FACIT collagens, vonWillebrand factor
(VWF) and integrins [11–13]. Recently, the determination of the
tridimensional structure of two P-III SVMPs revealed that the
cysteine-rich domain of proteins with the ADAMs metallo-
proteinase/disintegrin-like/cysteine-rich architecture show a
hyper-variable region (HVR), which has a novel fold stabilized
by conserved disulﬁde bonds, and constitutes a potential
protein–protein adhesive interface [14,15].
Previous studies have shown that TNF-a antibodies reduced
the size of venom-induced necrotic lesions, suggesting that
endogenous mechanisms of the inﬂammatory response can
be activated by SVMPs [16]. Moreover, a study on the inﬂam-
matory action of jararhagin, a hemorrhagic metalloproteinase
from the venom of Bothrops jararaca, showed that it is a po-
tent pro-inﬂammatory agent dependent on in situ activation
of macrophages [17]. The activation of macrophages by jar-
arhagin involves induction of TNF-a, IL1b and IL-6 expres-
sion, which is dependent on its proteolytic activity [18]. On
the other hand, it was recently shown that the disintegrin-
like/cysteine-rich domains of jararhagin are suﬃcient to locally
activate the early events of an acute inﬂammatory response as
leukocyte rolling and pro-inﬂammatory cytokine release [19].
HF3, a P-III SVMP of 62 kDa, is the most potent hemor-
rhagic toxin isolated from B. jararaca venom [20]. It causes
hemorrhage on rabbit skin with a minimum hemorrhagic
dose of 15 ng. Previously, we determined the complete amino
acid sequence of HF3 by molecular cloning and showed
that a recombinant protein composed of its disintegrin-like/
cysteine-rich domains (DC-HF3) inhibits collagen-inducedblished by Elsevier B.V. All rights reserved.
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HF3 and DC-HF3 activate aMb2-mediated phagocytosis of
opsonized-zymosan particles by macrophages and this activity
is inhibited by anti-aM and anti-b2 antibodies. The catalytic
activity of HF3 did not contribute to its ability to stimulate
phagocytosis by macrophages suggesting a role for the disinte-
grin-like/cysteine-rich domains of HF3 in the activation of
phagocytosis mediated by aMb2 integrin [21].
In order to further investigate the eﬀect of HF3 and of its
individual disintegrin-like (D) and cysteine-rich (C) domains
on the pro-inﬂammatory response we tested for the ﬁrst time
in parallel the ability of recombinant proteins obtained in fu-
sion with glutathione S-transferase (GST), composed of the
domains together (GST-DC), and individually (GST-D and
GST-C), and showed that only proteins containing the cys-
teine-rich domain, GST-DC and GST-C, have the ability to
promote leukocyte rolling in the microcirculation as examined
by intravital microscopy. We also showed that peptides corre-
sponding to the HVR of the cysteine-rich domain of HF3 and
berythractivase, a P-III non-hemorrhagic, pro-coagulant
SVMP from B. erythromelas venom [22] can activate leukocyte
rolling. Leukocyte rolling induced by the cysteine-rich domain
and the HVR of HF3 was inhibited by anti-aM/b2 antibodies,
suggesting a role for this region in triggering the aMb2-medi-
ated pro-inﬂammatory eﬀects of HF3.
2. Materials and methods
2.1. Animals
Male Swiss mice (18–20 g) were housed in temperature controlled
rooms and received water and food ad libitum. These studies were ap-
proved by the Experimental Animals Committee of Butantan Institute
according to the procedures laid down by the Universities Federation
for Animal Welfare.
2.2. Expression of the non-catalytic domains of HF3 in E. coli
The disintegrin-like/cysteine-rich domains of HF3 (GST-DC) was
obtained in E. coli DH5a, as described earlier [21]. For the expression
of the disintegrin-like domain the constructs pGEX-4T2-D16 (contain-
ing cDNA encoding amino acid residues 396–493 of HF3; GenBank
AAG48931) and pGEX-4T2-D18 (containing cDNA encoding amino
acid residues 396–505) were used; the construct to express the cys-
teine-rich domain (pGEX-4T2-C) contained amino acid residues 494-
606. The following primers were used to amplify the sequences from
the cDNA encoding the HF3 precursor by PCR:
Disintegrin-like (D16) – sense: 5 0CGGAATTCCATTGAGAACA
GATATT 3 0, with a EcoRI restriction site; antisense: 3 0
TTACCTGTTGGTACGACTGAGCTCGCC 5 0, with a XhoI restric-
tion site.
Disintegrin-like (D18) – sense: 5 0CGGAATTCCATTGAGAACA
GATATT 3 0, with a EcoRI restriction site; antisense: 3 0 ATGT
TACCCTTAACGACTGAGCTCGCC 5 0, with a XhoI restriction
site.
Cysteine-rich (C) – sense: 5 0-AGGAATTCTACTACATAACTACG
GTTAC-3 0, with a EcoRI restriction site; antisense: 3 0-CGACTC
GAGCGGCCGCATGCTGA-50 with a NotI restriction site.
To generate fusion proteins with GST the PCR products were di-
rectly subcloned into the pGEX-4T2 vector (GE Healthcare). Plasmids
were sequenced on both strands to ensure that the coding sequences
were correct. The constructed plasmids were transformed into E. coli
DH5a, and grown in 50 ml Luria-Bertani medium containing
100 lg ml1 ampicillin at 37 C to a cell density of A600 = 0.6–0.8. Pro-
tein expression was induced by adding 0.5 mM isopropyl-thio-b-D-
galactopyranoside (IPTG) and incubation was continued for 3 h at
30 C. Cells were collected by centrifugation at 4000 · g for 5 min
and suspended in 1 ml lysis buﬀer (50 mM Tris–HCl pH 7.5,
150 mM NaCl, 1% Triton X-100). After lysis by sonication the cell ly-
sate was centrifuged and 80 ll of Glutathione-Sepharose (GE Health-
care) suspension were added to supernatant and incubated 16 h at4 C. The resin was washed successively with lysis buﬀer to eliminate
unbound proteins and incubated with thrombin cleavage buﬀer
(50 mM Tris–HCl pH 8.0, 150 mM NaCl, 2.5 mM CaCl2) and 4U
thrombin (Sigma) for 2 h at 37 C. Recombinant proteins obtained
in the supernatant (GST-D16, GST-D18 and GST-C) were analyzed
by SDS–PAGE, Western-blot and N-terminal amino acid sequencing.
2.3. Intravital microscopy assays
Mice were injected with a muscle relaxant drug (0.4% Xilazin)
(Coopazine, Schering-Plough) and then anaesthetized with 2.5%
chloral hydrate and the cremaster muscle was exposed for microscopic
examination in situ as described by Lomonte et al. [23]. The number of
rolling leukocytes was quantiﬁed as described by Shigematsu et al. [24].
Animals were maintained on a board thermostatically controlled at
37 C, which included a transparent platform on which the tissue to
be transilluminated was placed. After stabilization of the microcircula-
tory network, the alterations were visualized in post-capillary venules
for 30 min after topical application of 20 ll solution of recombinant
proteins at 5 lM or 15 lM, or synthetic peptides at 50 lM in PBS.
Leukocyte rolling velocity was measured for the ﬁrst ﬁve leukocytes
entering the ﬁeld of view at the time of recording and calculated from
the average time required for a leukocyte to roll along a 500-lm length
of venule. To evaluate the role of aMb2 integrin on cysteine-rich do-
main- and peptide-induced leukocyte rolling, mice were injected in
the ophthalmic plexus with 50 lg or 25 lg, respectively, of each mono-
clonal antibody in 100 ll PBS (anti-aM, clone 5C6, Serotec; anti-b2,
clone YTS213.1, Serotec), and after 30 min GST-C or the peptide
HF3-HVR1 was topically applied. Values are average of three inde-
pendent experiments. The analysis of the microvascular system was
performed with an optical microscope (Image.A1 Carl-Zeiss) coupled
to a photographic camera (AxioCam ICc1) using an objective 40·/03.
2.4. Peptide synthesis
Peptides based on the HVR of HF3 and berythractivase were syn-
thesized using an automatic synthesizer PSSM8 (Shimadzu) by the so-
lid phase peptide synthesis FMOC strategy [25]. Peptides were puriﬁed
by preparative reversed-phase chromatography (RP-HPLC), and the
purity and identity of the peptides were conﬁrmed by MALDI-TOF
mass spectrometry on a Ettan Maldi-Tof/Pro instrument (Amersham
Biosciences), and by analytical RP-HPLC in two diﬀerent solvent sys-
tems. Oxidation of cysteinyl residues was carried out using oxygen in
diluted aqueous solution of peptide in basic pH. Following oxidation,
the peptide was lyophilized and puriﬁed by RP-HPLC.
2.5. Analytical procedures
Protein concentrations were determined by the Bio-Rad protein as-
say kit using bovine serum albumin as a standard. Sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS–PAGE) was carried out
according to Laemmli [26]. Western-blot analysis was performed as de-
scribed by Burnette [27]. For N-terminal sequencing, proteins were
transferred to 0.2-lm pore PVDF membrane (Applied Biosystems)
using the Transphor apparatus (GE Healthcare). Protein bands stained
with Coomassie blue were sequenced in an Applied Biosystems 494
Procise sequencer using the manufacturers pulsed liquid PVDF cycles.3. Results and discussion
3.1. Expression of the individual non-catalytic domains of HF3
For the analysis of the ability of the non-catalytic domains
of HF3 to activate leukocyte rolling we obtained the disinte-
grin-like and cysteine-rich domains together (GST-DC), and
individually (GST-D and GST-C). The disintegrin-like domain
was expressed in two versions considering the disulﬁde bonds
observed in the crystal structure of P-III SVMPs VAP1 [14]
and catrocollastatin/VAP2B [15]: D16 contains 16 Cys residues
and D18 contains 18 Cys residues, including the disulﬁde
bridge (Cys468–Cys499) which connects the disintegrin-like
and cysteine-rich domains and stabilizes the continuous struc-
ture of the disintegrin-like domain (Fig. 1A). The cDNA
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Fig. 1. Expression of HF3 non-catalytic domains. (A) Comparison of HF3 and VAP1 disintegrin-like/cysteine-rich domain sequences. Disulﬁde
bonds of VAP1 are depicted [14]. Cysteine residues are underlined. Double-headed arrows indicate the sequence of HF3 recombinant proteins. The
HVR is shaded in grey. (B) SDS–PAGE of molecular mass markers (lanes 1 and 6), GST-D16 (lane 2), GST-D18 (lane 3), GST-C (lane 7) puriﬁed by
glutathione-Sepharose 4B chromatography, and Western-blot of puriﬁed GST-D16 (lane 4), GST-D18 (lane 5) and GST-C (lane 8) identiﬁed with
anti-HF3 antibody.
M.C. Menezes et al. / FEBS Letters 582 (2008) 3915–3921 3917sequences coding for the disintegrin-like and cysteine-rich do-
mains of HF3 were subcloned in the expression vector pGEX-
4T2, and the resultant plasmids were used to transform E. coli
DH5a cells, and protein expression was induced with 0.5 mM
IPTG for 3 h. The recombinant fusion proteins GST-D16,
GST-D18 and GST-C were detected by SDS–PAGE and by
Western-blot using anti-HF3 antibodies [20] as 40 kDa pro-
teins (Fig. 1B), which shifted to 12 kDa after release of GST
by thrombin (not shown) and showed the N-terminal amino
acid sequences G-S-P-G-I-P-L-R-T-D-I-V-S-P (D16 and
D18) and G-S-P-G-I-P-L-H-N (C) where the italicized letters
correspond to amino acid residues encoded by the vector.
The yield of the GST-D16 and GST-D18 proteins was esti-
mated as 2 mg/l culture medium while GST-C yielded 1 mg/l.
3.2. Eﬀect of the non-catalytic domains of HF3 on the rolling of
leukocytes in the microcirculation
In a previous study we showed the ability of HF3 to activate
macrophages for phagocytosis through the integrin aMb2 and
suggested that the disintegrin-like/cysteine-rich domains are
important for this eﬀect since a recombinant protein corre-
sponding to these domains recapitulated the eﬀects of native
HF3 [20]. Moreover, orthophenanthroline-inactivated HF3was also able to activate macrophages for phagocytosis, indi-
cating that the proteolytic activity of HF3 was not important
for the interaction with integrin aMb2. Recent studies have
indicated that it is the cysteine-rich domain of P-III SVMPs
that functions as a targeting exosite for interaction with their
substrates. We showed that the recombinant cysteine-rich
domain of P-III SVMP atrolysin A was able to bind VWF
[11], FACIT collagens and matrilins [12]. Synthetic peptides
from the cysteine-rich domain of atrolysin A and of jararhagin
were shown to block collagen-stimulated platelet-aggregation,
presumably by binding integrin a2b1 [7]. Similar peptides were
recently shown to bind to VWF and to block the binding of the
cysteine-rich domain to VWF [28]. These data clearly identify
the cysteine-rich domain as the key substrate targeting domain
in P-III SVMPs.
In this work we investigated the eﬀect of HF3 and its disin-
tegrin-like/cysteine-rich domains expressed together (GST-
DC) or individually (GST-D16, GST-D18 and GST-C) in
the pro-inﬂammatory response by analyzing the alterations
on the microcirculatory network using intravital microscopy
by transillumination of mice cremaster muscle. The ﬁrst obser-
vation from these experiments is that none of these proteins
interfered with microvasculature haemodynamic parameters,
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(not shown). HF3 induced leukocyte rolling at 1.6 nM
(Fig. 2), however, at higher doses it also caused hemorrhage
(not shown). The proteins GST, GST-D16 and GST-D18 at
15 lM did not aﬀect the number of rolling leukocytes, which
remained at the basal level of ±20 leukocytes per min
(Fig. 2); on the other hand, GST-DC and GST-C proteins at
5 lM increased the number of rolling leukocytes to 100 or
higher per min in post-capillary venules between 15 and
30 min after topical application, suggesting that only the pro-
teins containing the cysteine-rich domain (GST-DC and GST-
C) were able to aﬀect leukocyte rolling (Fig. 2). Furthermore,
GST-DC and GST-C promoted adhesion of part of the leuko-
cytes to the endothelial wall with transmigration being ob-
served in some instances (Fig. 2B and D). These data
corroborate the role of the cysteine-rich domain in the interac-
tion of P-III SVMPs with their targets in vivo. Moreover, here
we conﬁrm the role of integrin aMb2 in the pro-inﬂammatory
eﬀects of HF3 as monoclonal antibodies anti-aM and anti-b2,
injected in mice prior to the application of GST-C, abolished
leukocyte rolling (Fig. 2).
3.3. Eﬀect of synthetic peptides from the HVR on the rolling of
leukocytes in the microcirculation
The recently determined crystal structures of two P-III
SVMPs, VAP1 and catrocollastatin/VAP2B showed that in0
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sequences and was suggested to constitute a potential protein–
protein adhesive interface (Fig. 1A). In VAP1 and catrocollast-
atin/VAP2B, the HVR is located at the distal end of the arm
constituted by disintegrin-like domain and faces toward the
catalytic site [14,15]. Here we investigated the eﬀect of syn-
thetic peptides corresponding to the HVR of HF3 and berythr-
activase, a pro-coagulant SVMP from B. erythromelas [22] in
leukocyte rolling in the endothelium (Table 1). As most P-III
SVMPs, the HVR of HF3 contains one conserved Cys residue
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HF3 and berythractivase, the peptides HF3-HVR1 and bery-
thractivase-HVR1 at 50 lM signiﬁcantly increased the rolling
of leukocytes suggesting that this region of both hemorrhagicand non-hemorrhagic SVMPs may be involved in triggering
pro-inﬂammatory eﬀects. Both HF3-HVR1 and berythracti-
vase-HVR1 peptides contained a disulﬁde bond, which was
not present in peptides HF3-HVR2 and berythractivase-
3920 M.C. Menezes et al. / FEBS Letters 582 (2008) 3915–3921HVR2, in which the cysteinyl residues were substituted by ala-
nyl residues. The lack of Cys residues in these peptides caused
a moderate but signiﬁcant eﬀect of decreasing the activation of
leukocyte rolling (Fig. 3), indicating that the conformational
constraint imposed by the disulﬁde bond may be important
for the expression of the peptide pro-inﬂammatory activity.
The signiﬁcance of Cys residues in the HVR of HF3 was con-
ﬁrmed by testing a linear peptide (HF3-HVR3) that lacked the
disulﬁde bond. The eﬀect of this peptide on the microcirculato-
ry network was rather unexpected as it caused such blood ﬂow
lowering in post-capillary venules that made it impossible to
evaluate leukocyte rolling (not shown). Nevertheless, it is clear
that the cysteinyl residue in the HVR of HF3 plays a role in
HF3 eﬀects in the microcirculatory network. As observed with
GST-C, anti-aM/b2 antibodies signiﬁcantly prevented leuko-
cyte rolling induced by peptide HF3-HVR1 (Fig. 3).
We also tested peptides derived from sequences adjacent to
the HVR of HF3 (Table 1). Interestingly, peptides corre-
sponding to sequences ﬂanking the N-terminal region of the
HVR (HF3-CR3 and HF3-CR4) and the C-terminal region
of HVR (HF3-CR5 and HF3-CR6) also induced leukocyte
rolling (Fig. 3), suggesting that the C-terminal part of the
cysteine-rich domain and not only the HVR may constitute
a potential interacting interface. Finally, we tested the corre-
sponding sequence of HF3 (peptides HF3-CR1 and HF3-
CR2; Table 1) where three P-III class SVMPs (HR1B, Bjus-
suMP_I, and kaouthiagin) have the integrin-binding motifs
KGD or RGD in their cysteine-rich domains [5], while
HF3 has a NGD motif. Peptide HF3-CR1, which contains a
disulﬁde bond, showed no eﬀect on leukocyte activation for
rolling (Fig. 3), while the corresponding linear peptide
(HF3-CR2) caused a striking blood ﬂow lowering in post-
capillary venules as was observed with HF3-HVR3 (not
shown). Taken together, these data suggest that this portion
of the cysteine-rich domain is not involved in the eﬀects of
HF3 on leukocytes.
It has been suggested that the HVR of ADAMs and SVMPs,
but not the disintegrin domain should be the focus of searches
for physiological targets of these enzymes [14]. This is the ﬁrst
report on the evaluation of the pro-inﬂammatory eﬀects of re-
combinant individual non-catalytic domains of a P-III SVMP
that clearly shows the role of the cysteine-rich domain and of
its HVR in the activation of leukocyte rolling in the endothe-
lium. An increasing body of evidence has emerged showing
that proteins of the ADAM family critically act as regulators
of cell migration in inﬂammation and invasion [29]. Integrins
participate in rolling and mediate leukocyte adhesion. They
are activatable receptors since intracellular signaling through
cell-surface molecules is required to increase their ligand-
binding capability [30]. The aMb2 integrin can be activated
by inside-out or outside-in signaling mechanisms to generate
high-aﬃnity binding sites on the integrin [31,32]. It is one of
the key players of both phagocytic processes by macrophages,
and leukocyte rolling and migration. Our previous work show-
ing the activation of macrophage phagocytosis via aMb2 inte-
grin by the disintegrin-like/cysteine-rich domains of HF3 is
in agreement with the ﬁndings of the present work that suggest
that the cysteine-rich domain and its HVR may activate aMb2
integrin for leukocyte rolling. Although there is only limited
structural homology shared by the cysteine-rich domains of
the P-III SVMPs and the ADAMs and ADAMTSs, our results
suggest an analogous role for the cysteine-rich domains incertain members of the ADAM and ADAMTS families of
proteins in inﬂammatory processes.
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